| Schedule of Condensed Statements of Income |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
Stock compensation expense |
|
$ |
25,200 |
|
|
$ |
18,225 |
|
|
$ |
19,464 |
|
Equity in net loss (income) from subsidiaries |
|
|
253,571 |
|
|
|
(97,764 |
) |
|
|
(77,764 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
(278,771 |
) |
|
|
79,539 |
|
|
|
58,300 |
|
Other comprehensive income (loss), net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
Pension and postretirement benefits |
|
|
1,938 |
|
|
|
2,430 |
|
|
|
(7,958 |
) |
Net gain (loss) from hedging activities |
|
|
166 |
|
|
|
(2,665 |
) |
|
|
(330 |
) |
Foreign currency translation |
|
|
(16,596 |
) |
|
|
22,117 |
|
|
|
(35,127 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
Total other comprehensive (loss) income |
|
|
(14,492 |
) |
|
|
21,882 |
|
|
|
(43,415 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive (loss) income |
|
$ |
(293,263 |
) |
|
$ |
101,421 |
|
|
$ |
14,885 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Schedule of Condensed Balance Sheets |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Investment in subsidiaries |
|
$ |
1,277,126 |
|
|
$ |
1,779,450 |
|
| |
|
|
|
|
|
|
|
|
| |
|
$ |
1,277,126 |
|
|
$ |
1,779,450 |
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
$ |
— |
|
|
$ |
— |
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Common stock (0.01 par); authorized shares 450,000,000; issued shares 137,102,143 and 136,861,382 on December 31, 2020 and 2019, respectively; outstanding shares 136,318,557 and 136,464,961 on December 31, 2020 and 2019, respectively |
|
|
1,371 |
|
|
|
1,369 |
|
Preferred stock (0.01 par); authorized shares 50,000,000; no shares issued or outstanding on December 31, 2020 and 2019, respectively |
|
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
|
1,477,859 |
|
|
|
1,696,899 |
|
(Accumulated deficit) retained earnings |
|
|
(175,758 |
) |
|
|
103,013 |
|
Treasury stock, at cost; shares 783,586 and 396,421 on December 31, 2020 and 2019, respectively |
|
|
(11,081 |
) |
|
|
(6,483 |
) |
Accumulated other comprehensive loss |
|
|
(15,265 |
) |
|
|
(15,348 |
) |
| |
|
|
|
|
|
|
|
|
Total Ecovyst Inc. equity |
|
|
1,277,126 |
|
|
|
1,779,450 |
|
| |
|
|
|
|
|
|
|
|
Total liabilities and equity |
|
$ |
1,277,126 |
|
|
$ |
1,779,450 |
|
| |
|
|
|
|
|
|
|
|
|
| Schedule of Condensed Statements of Cash Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
$ |
(278,771 |
) |
|
$ |
79,539 |
|
|
$ |
58,300 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Equity in net income from subsidiarie s
|
|
|
253,571 |
|
|
|
(97,764 |
) |
|
|
(77,764 |
) |
Stock compensation expense |
|
|
25,200 |
|
|
|
18,225 |
|
|
|
19,464 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Distribution from subsidiaries |
|
|
243,779 |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by investing activities |
|
|
243,779 |
|
|
|
— |
|
|
|
— |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
|
|
|
|
Dividends paid to stockholders |
|
|
(243,779 |
) |
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(243,779 |
) |
|
|
— |
|
|
|
— |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Net change in cash, cash equivalents and restricted cash |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Cash, cash equivalents and restricted cash at beginning of period |
|
|
— |
|
|
|
— |
|
|
|
— |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and restricted cash at end of period of continuing operations |
|
$ |
—
|
|
|
$ |
—
|
|
|
$ |
—
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|